Daniele Mattei

3.5k total citations
24 papers, 665 citations indexed

About

Daniele Mattei is a scholar working on Hematology, Genetics and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Daniele Mattei has authored 24 papers receiving a total of 665 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Hematology, 12 papers in Genetics and 9 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Daniele Mattei's work include Chronic Lymphocytic Leukemia Research (11 papers), Acute Lymphoblastic Leukemia research (9 papers) and Chronic Myeloid Leukemia Treatments (7 papers). Daniele Mattei is often cited by papers focused on Chronic Lymphocytic Leukemia Research (11 papers), Acute Lymphoblastic Leukemia research (9 papers) and Chronic Myeloid Leukemia Treatments (7 papers). Daniele Mattei collaborates with scholars based in Italy, France and United States. Daniele Mattei's co-authors include Andrea Gallamini, Nicola Mordini, Cristiana Lo Nigro, Claudio Romani, Giuseppe Rossi, Alessandro Rambaldi, Tamara Intermesoli, Enrico Maria Pogliani, Elisabetta Terruzzi and Renato Bassan and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Daniele Mattei

21 papers receiving 651 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Daniele Mattei Italy	11	296	218	200	157	128	24	665
Jason Butler Australia	12	595 2.0×	104 0.5×	210 1.1×	56 0.4×	57 0.4×	43	900
EP Smith United States	8	387 1.3×	61 0.3×	256 1.3×	171 1.1×	108 0.8×	11	697
Ivan Moiseev Russia	13	336 1.1×	105 0.5×	209 1.0×	98 0.6×	55 0.4×	149	611
Eugenia Giraldi Italy	11	518 1.8×	153 0.7×	247 1.2×	48 0.3×	72 0.6×	22	885
Yoshiko Matsuhashi Japan	12	336 1.1×	73 0.3×	147 0.7×	66 0.4×	35 0.3×	41	521
R. Or Israel	16	698 2.4×	130 0.6×	267 1.3×	60 0.4×	42 0.3×	48	1.0k
Fábio R. Kerbauy Brazil	11	291 1.0×	72 0.3×	153 0.8×	58 0.4×	61 0.5×	45	474
Sameem Abedin United States	18	378 1.3×	91 0.4×	220 1.1×	32 0.2×	105 0.8×	68	890
Luís Fernando S. Bouzas Brazil	13	627 2.1×	163 0.7×	182 0.9×	24 0.2×	60 0.5×	27	868
Takayoshi Tachibana Japan	13	330 1.1×	94 0.4×	112 0.6×	88 0.6×	20 0.2×	81	530

Countries citing papers authored by Daniele Mattei

Since Specialization

Citations

This map shows the geographic impact of Daniele Mattei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniele Mattei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniele Mattei more than expected).

Fields of papers citing papers by Daniele Mattei

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniele Mattei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniele Mattei. The network helps show where Daniele Mattei may publish in the future.

Co-authorship network of co-authors of Daniele Mattei

This figure shows the co-authorship network connecting the top 25 collaborators of Daniele Mattei. A scholar is included among the top collaborators of Daniele Mattei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniele Mattei. Daniele Mattei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Castellino, Claudia, et al.. (2025). Next-Generation Therapies in Mantle Cell Lymphoma (MCL): The Evolving Landscape in Treatment of Relapse/Refractory After CAR-T Cells. Cancers. 17(13). 2239–2239. 1 indexed citations

Castellino, Alessia, Roberto Sorasio, Claudia Castellino, et al.. (2021). Diagnosis of maternal Hodgkin lymphoma following abnormal findings at noninvasive prenatal screening test (NIPT): Report of two cases. SHILAP Revista de lepidopterología. 9(3). 1066–1071. 1 indexed citations

Castellino, Alessia, Claudia Castellino, Margherita Bonferroni, et al.. (2020). Immunoglobulin M (IgM) multiple myeloma versus Waldenström macroglobulinemia: diagnostic challenges and therapeutic options: two case reports. Journal of Medical Case Reports. 14(1). 75–75. 6 indexed citations

Sorasio, Roberto, Margherita Bonferroni, Mariella Grasso, et al.. (2014). Peripheral Blood CD34+ Percentage at Hematological Recovery after Chemotherapy Is a Good Early Predictor of Harvest: A Single-Center Experience. Biology of Blood and Marrow Transplantation. 20(5). 717–723. 10 indexed citations

Intermesoli, Tamara, Alessandro Rambaldi, Giuseppe Rossi, et al.. (2013). High cure rates in Burkitt lymphoma and leukemia: a Northern Italy Leukemia Group study of the German short intensive rituximab-chemotherapy program. Haematologica. 98(11). 1718–1725. 34 indexed citations

Bassan, Renato, Orietta Spinelli, Elena Oldani, et al.. (2012). Early Response Dynamics Including Minimal Residual Disease (MRD) and Adherence to Risk/MRD-Oriented Therapy Are Major Outcome Determinants in Adult Ph-Negative Acute Lymphoblastic Leukemia (ALL).. Blood. 120(21). 2573–2573.

Bassan, Renato, Orietta Spinelli, Elena Oldani, et al.. (2012). In Adult Acute Lymphoblastic Leukemia (ALL) Different Minimal Residual Disease (MRD) Levels Predict Clinical Outcome in All Patients and Response to Allogeneic/Autologous Transplantation in MRD-Positive Patients.. Blood. 120(21). 2493–2493.

Intermesoli, Tamara, Alessandro Rambaldi, Chiara Cattaneo, et al.. (2012). High Cure Rates in Burkitt Leukemia and Lymphoma: NILG Study of the German Short Intensive Rituximab-Chemotherapy Program. Blood. 120(21). 1494–1494.

Cortelazzo, Sergio, Tamara Intermesoli, Elena Oldani, et al.. (2011). Results of a lymphoblastic leukemia-like chemotherapy program with risk-adapted mediastinal irradiation and stem cell transplantation for adult patients with lymphoblastic lymphoma. Annals of Hematology. 91(1). 73–82. 28 indexed citations

10.

Bassan, Renato, Giuseppe Rossi, Enrico Maria Pogliani, et al.. (2010). Chemotherapy-Phased Imatinib Pulses Improve Long-Term Outcome of Adult Patients With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Northern Italy Leukemia Group Protocol 09/00. Journal of Clinical Oncology. 28(22). 3644–3652. 182 indexed citations

11.

Bassan, R, Tamara Intermesoli, Elena Oldani, et al.. (2008). Short-course imatinib (IM) added to chemotherapy improves early but not long-term outcome in adult Ph/BCR-ABL+ acute lymphoblastic leukemia (ALL) : 5-year follow-up results of study NILG-09. Haematologica. 93. 366–367. 4 indexed citations

12.

Latagliata, Roberto, Massimo Breccia, Paola Fazi, et al.. (2008). Liposomal daunorubicin versus standard daunorubicin: long term follow‐up of the GIMEMA GSI 103 AMLE randomized trial in patients older than 60 years with acute myelogenous leukaemia. British Journal of Haematology. 143(5). 681–689. 38 indexed citations

13.

Pagano, Livio, Andrea Gallamini, Giulio Trapè, et al.. (2006). NK/T-cell lymphomas ‘nasal type’: an Italian multicentric retrospective survey. Annals of Oncology. 17(5). 794–800. 56 indexed citations

14.

Bruno, Benedetto, Francesca Patriarca, Roberto Sorasio, et al.. (2006). Bortezomib with or without dexamethasone in relapsed multiple myeloma following allogeneic hematopoietic cell transplantation.. PubMed. 91(6). 837–9. 31 indexed citations

15.

Bassan, Renato, Orietta Spinelli, Elena Oldani, et al.. (2005). Minimal Residual Disease (MRD) and Risk-Oriented Therapy in Adult Acute Lymphoblastic Leukemia (ALL).. Blood. 106(11). 1836–1836. 1 indexed citations

16.

Bonferroni, Margherita, et al.. (2004). Risk Factors of Cytomegalovirus Infection in Autologous Stem Cell Transplantation (ASCT).. Blood. 104(11). 5219–5219. 2 indexed citations

17.

Mattei, Daniele, et al.. (2004). False-Positive Aspergillus Galactomannan Enzyme-Linked Immunosorbent Assay Results In Vivo during Amoxicillin-Clavulanic Acid Treatment. Journal of Clinical Microbiology. 42(11). 5362–5363. 73 indexed citations

18.

Mattei, Daniele, et al.. (2003). Successful treatment of Acremonium fungemia with voriconazole. Mycoses. 46(11-12). 511–514. 47 indexed citations

19.

Mattei, Daniele, Nicola Mordini, Cristiana Lo Nigro, et al.. (2002). Voriconazole in the management of invasive aspergillosis in two patients with acute myeloid leukemia undergoing stem cell transplantation. Bone Marrow Transplantation. 30(12). 967–970. 17 indexed citations

20.

Santini, Gino, S Nati, Mauro Spriano, et al.. (2001). Fludarabine in combination with cyclophosphamide or with cyclophosphamide plus mitoxantrone for relapsed or refractory low-grade non-Hodgkin's lymphoma.. CINECA IRIS Institutial Research Information System (University of Genoa). 86(3). 282–6. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact